Claybrook Capital LLC Purchases New Holdings in UnitedHealth Group Inc (UNH)

Share on StockTwits

Claybrook Capital LLC purchased a new stake in UnitedHealth Group Inc (NYSE:UNH) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 370 shares of the healthcare conglomerate’s stock, valued at approximately $92,000.

Other institutional investors have also added to or reduced their stakes in the company. Oregon Public Employees Retirement Fund raised its holdings in UnitedHealth Group by 50,446.5% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 53,349,795 shares of the healthcare conglomerate’s stock worth $214,000 after purchasing an additional 53,244,249 shares during the last quarter. BlackRock Inc. raised its holdings in UnitedHealth Group by 3.1% during the 4th quarter. BlackRock Inc. now owns 69,831,381 shares of the healthcare conglomerate’s stock worth $17,396,391,000 after purchasing an additional 2,123,417 shares during the last quarter. Rehmann Capital Advisory Group raised its holdings in UnitedHealth Group by 26,088.2% during the 3rd quarter. Rehmann Capital Advisory Group now owns 1,723,185 shares of the healthcare conglomerate’s stock worth $6,477,000 after purchasing an additional 1,716,605 shares during the last quarter. Vanguard Group Inc raised its holdings in UnitedHealth Group by 1.6% during the 3rd quarter. Vanguard Group Inc now owns 69,342,549 shares of the healthcare conglomerate’s stock worth $18,447,892,000 after purchasing an additional 1,073,505 shares during the last quarter. Finally, Vanguard Group Inc. raised its holdings in UnitedHealth Group by 1.6% during the 3rd quarter. Vanguard Group Inc. now owns 69,342,549 shares of the healthcare conglomerate’s stock worth $18,447,892,000 after purchasing an additional 1,073,505 shares during the last quarter. 86.68% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group stock opened at $221.75 on Friday. The stock has a market cap of $220.89 billion, a PE ratio of 17.22, a P/E/G ratio of 1.18 and a beta of 0.79. UnitedHealth Group Inc has a 1 year low of $208.07 and a 1 year high of $287.94. The company has a debt-to-equity ratio of 0.64, a current ratio of 0.73 and a quick ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.60 by $0.13. The company had revenue of $60.30 billion during the quarter, compared to analyst estimates of $59.72 billion. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the previous year, the company earned $3.04 EPS. Equities analysts forecast that UnitedHealth Group Inc will post 14.63 EPS for the current year.

In other news, Director Gail R. Wilensky sold 2,930 shares of the business’s stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $253.39, for a total transaction of $742,432.70. Following the completion of the transaction, the director now directly owns 64,726 shares in the company, valued at approximately $16,400,921.14. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, January 22nd. The shares were sold at an average price of $266.61, for a total value of $1,333,050.00. Following the completion of the transaction, the director now owns 77,702 shares of the company’s stock, valued at $20,716,130.22. The disclosure for this sale can be found here. Insiders have sold a total of 17,930 shares of company stock valued at $4,587,133 over the last 90 days. Corporate insiders own 0.87% of the company’s stock.

Several analysts have weighed in on the company. ValuEngine cut UnitedHealth Group from a “hold” rating to a “sell” rating in a report on Thursday. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $258.00 price objective for the company in a report on Wednesday. Citigroup dropped their price objective on UnitedHealth Group from $288.00 to $247.00 and set a “neutral” rating for the company in a report on Wednesday. Barclays dropped their price objective on UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating for the company in a report on Wednesday. Finally, Bank of America reissued a “buy” rating and set a $290.00 price objective (down from $320.00) on shares of UnitedHealth Group in a report on Wednesday. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $291.56.

WARNING: “Claybrook Capital LLC Purchases New Holdings in UnitedHealth Group Inc (UNH)” was first reported by Zolmax and is owned by of Zolmax. If you are accessing this article on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The original version of this article can be viewed at https://zolmax.com/investing/claybrook-capital-llc-purchases-new-holdings-in-unitedhealth-group-inc-unh/3046085.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: What is the Federal Reserve?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

-$1.20 EPS Expected for Catalyst Biosciences Inc  This Quarter
-$1.20 EPS Expected for Catalyst Biosciences Inc This Quarter
Brokerages Set $48.00 Target Price for Lydall, Inc.
Brokerages Set $48.00 Target Price for Lydall, Inc.
First Republic Bank  Earns “Outperform” Rating from Wedbush
First Republic Bank Earns “Outperform” Rating from Wedbush
Littelfuse  Cut to Sell at Zacks Investment Research
Littelfuse Cut to Sell at Zacks Investment Research
Control4  Lowered to “Strong Sell” at BidaskClub
Control4 Lowered to “Strong Sell” at BidaskClub
Domino’s Pizza  Issues Quarterly  Earnings Results, Beats Expectations By $0.19 EPS
Domino’s Pizza Issues Quarterly Earnings Results, Beats Expectations By $0.19 EPS


 
© 2006-2019 Zolmax.